Rep. Waxman Can Move Follow-On Biologics In New Role As Energy and Commerce Chairman
This article was originally published in The Pink Sheet Daily
Executive Summary
Victory over "Dean of the House" Dingell puts Waxman in the driver's seat to steer major legislation impacting the drug industry.
You may also be interested in...
Senate Biosimilars Bill Readied For Take-Off In Next Congress
Kennedy will enter 111th Congress with a ready-to-go bill after committee officially reports out S. 1695 last week.
Senate Biosimilars Bill Readied For Take-Off In Next Congress
Kennedy will enter 111th Congress with a ready-to-go bill after committee officially reports out S. 1695 last week.
Who Should Be The Next FDA Commissioner? David Kessler Weighs In
Former FDA Commissioner David Kessler has a few ideas about the kind of person President-elect Barack Obama should pick to succeed Andrew von Eschenbach at FDA after he takes office Jan. 20